Skip to main content
AKBA $0.42 +3.28%
AKBA logo
AKBA · Akebia Therapeutics, Inc.
Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M
All webcasts

Earnings call · FY2024 Q2

Akebia Therapeutics, Inc. (AKBA) Q2 2024 Earnings Call

Concluded Aug 8, 2024
Aug 8, 2024
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
Revenue $43.65M -22.6% YoY
Diluted EPS -$0.04
Gross margin · derived Q4 60.9% -8.4 pp YoY
Net income -$8.58M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document